Influenza vaccine supply chain network design during the COVID-19 pandemic considering dynamical demand

Document Type : Article


1 Department of Industrial Engineering, Iran University of Science and Technology Tehran, Iran

2 Department of Industrial Engineering, Babol Noshirvani University of Technology Babol, Iran


Nowadays, the healthcare industry focuses on the COVID-19 more than any other issues. There are many close similarities between the symptoms of the coronavirus and the Influenza (flu) virus, which sometimes make it difficult to distinguish between them. So, it has prompted countries to start flu vaccination to prevent potential problems. To consider it, this study presents a multi-level supply chain for the flu vaccine during the COVID-19 pandemic. The problem pursues three main goals: cost minimization, maximizing demand allocation based on customer prioritization, and minimizing maximum lost customer demand. Due to the limited number of vaccines, a rate indicating the priority of each group of customers to receive the vaccine in the proposed model is considered. Customer prioritization can undermine justice because a flu patient is in critical condition but has low priority. Therefore, the third objective seeks to create justice and morality by minimizing the maximum lost demand. To evaluate the model, it is conducted based on a case study in Mazandaran province, Iran. The findings illuminate that 79 % of the demand will be met. Besides it shows that by increasing the capacity to 10%, the demand will be satisfied 9 percent more.


  1. References

     Meng Y, Jin M, Tang X, Xu J. "Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study". Applied soft computing. (2021).

    1. Garai A, Chowdhury S, Sarkar B, Roy TK. "Cost-effective subsidy policy for growers and biofuels-plants in closed-loop supply chain of herbs and herbal medicines: An interactive bi-objective optimization in T-environment". Applied Soft Computing.( 2021).
    2. Shahparvari S, Hasanizadeh B, Mohammadi A, Kiani B, Lau KH, Chhetri P, et al. "A Decision Support System for Prioritised COVID-19 Two-dosage Vaccination Allocation and Distribution". Available at SSRN 3762826. (2021).
    3. Fong SJ, Li G, Dey N, Crespo RG, Herrera-Viedma E. "Composite Monte Carlo decision making under high uncertainty of novel coronavirus epidemic using hybridized deep learning and fuzzy rule induction". Applied soft computing. (2020).
    5. Galazka A, Milstien J, Zaffran M. "Thermostability of vaccines" (WHO document ref. WHO/GPV/98.07). Geneva: WHO. (1998).
    6. Adu F, Adedeji A, Esan J, Odusanya O. "Live viral vaccine potency: an index for assessing the cold chain system". Public health. (1996).
    7. Hanjeet K, Lye M, Sinniah M, Schnur A. "Evaluation of cold chain monitoring in Kelantan, Malaysia". Bulletin of the World Health Organization. (1996).
    8. Thakker Y, Woods S. "Storage of vaccines in the community: weak link in the cold chain?" British medical journal. (1992).
    9. Casto DT, Brunell PA. "Safe handling of vaccines". Pediatrics. (1991).
    10. Ferguson NM, Keeling MJ, Edmunds WJ, Gani R, Grenfell BT, Anderson RM, et al. "Planning for smallpox outbreaks". Nature. (2003).
    11. Setia S, Mainzer H, Washington ML, Coil G, Snyder R, Weniger BG. "Frequency and causes of vaccine wastage". Vaccine. (2002).
    12. Omilabu S, Oyefolu A, Ojo O, Audu R. "Potency status and efficacy of measles vaccine administered in Nigeria: a case study of three EPI centres in Lagos, Nigeria". African journal of medicine and medical sciences. (1999).
    13. Oyefolu A, Nwaeke A, Audu R, Akinyemi K, Salu O, Muller C, et al. "Evaluation of Measles vaccine cold chain in Lagos state, Nigeria". African Journal of Clinical and Experimental Microbiology. (2007).
    14. Zuckerman JN. "Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines". Journal of medical virology. (2006).
    15. Yadav P. "Health product supply chains in developing countries: diagnosis of the root causes of underperformance and an agenda for reform". Health Systems & Reform. (2015).
    16. Health UDo, Services H. "HHS pandemic influenza plan". Washington (DC): The Department. (2005).
    17. Lee BY, Assi T-M, Rookkapan K, Wateska AR, Rajgopal J, Sornsrivichai V, et al. "Maintaining vaccine delivery following the introduction of the rotavirus and pneumococcal vaccines in Thailand". PloS one. (2011).
    18. Shittu E, Harnly M, Whitaker S, Miller R. "Reorganizing Nigeria’s vaccine supply chain reduces need for additional storage facilities, but more storage is required". Health Affairs. (2016).
    19. Huang H-C, Singh B, Morton DP, Johnson GP, Clements B, Meyers LA. "Equalizing access to pandemic influenza vaccines through optimal allocation to public health distribution points". PloS one. (2017).
    20. Chen X, Li M, Simchi-Levi D, Zhao T. "Allocation of COVID-19 vaccines under limited supply". Available at SSRN 3678986. (2020).
    21. Buccieri K, Gaetz S. "Ethical vaccine distribution planning for pandemic influenza: Prioritizing homeless and hard-to-reach populations". Public Health Ethics. (2013).
    22. Lin Q, Zhao Q, Lev B. "Cold chain transportation decision in the vaccine supply chain". European Journal of Operational Research. (2020).
    23. Sadjadi SJ, Ziaei Z, Pishvaee MS. "The design of the vaccine supply network under uncertain condition". Journal of Modelling in Management. (2019).
    24. Hogan AB, Campbell PT, Blyth CC, Lim FJ, Fathima P, Davis S, et al. "Potential impact of a maternal vaccine for RSV: a mathematical modelling study". Vaccine. (2017).
    25. Spicknall IH, Looker KJ, Gottlieb SL, Chesson HW, Schiffer JT, Elmes J, et al. "Review of mathematical models of HSV-2 vaccination: Implications for vaccine development". Vaccine. (2019).
    26. Pourmehdi M, Paydar MM, Asadi-Gangraj E. "Reaching sustainability through collection center selection considering risk: using the integration of Fuzzy ANP-TOPSIS and FMEA". Soft Computing. (2021).
    27. Kartoglu UH, Moore KL, Lloyd JS. "Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers". Vaccine. (2020).
    28. Farajzadeh F, Moadab A, Valilai OF, Houshmand M. "A Novel Mathematical Model for a Cloud-Based Drone Enabled Vehicle Routing Problem considering Multi-Echelon Supply Chain". IFAC-PapersOnLine. (2020).
    29. Hosseini SM, Paydar MM, Alizadeh M, Triki C. "Ecotourism supply chain during the COVID-19 pandemic: A real case study". Applied Soft Computing. (2021).
    30. Béraud G. "Mathematical models and vaccination strategies". vaccine. (2018).
    31. White MT, Verity R, Churcher TS, Ghani AC. "Vaccine approaches to malaria control and elimination: Insights from mathematical models". Vaccine. (2015).
    32. Mahajan K, Tomar S. "COVIDÔÇÉ19 and Supply Chain Disruption: Evidence from Food Markets in India". American journal of agricultural economics. (2021).
    33. Thul L, Powell W. "Stochastic Optimization for Vaccine and Testing Kit Allocation for the COVID-19 Pandemic". arXiv preprint arXiv:210101204. (2021).
    34. Westerink-Duijzer E, Schlicher L, Musegaas M. "Fair allocations for cooperation problems in vaccination". (2019).
    35. Keeling MJ, Shattock A. "Optimal but unequitable prophylactic distribution of vaccine. Epidemics". (2012).
    36. Teytelman A, Larson RC. "Multiregional dynamic vaccine allocation during an influenza epidemic". Service Science. (2013).
    37. Kaufmann JR, Miller R, Cheyne J. "Vaccine supply chains need to be better funded and strengthened, or lives will be at risk". Health Affairs. (2011).
    38. Seib K, Pollard AJ, de Wals P, Andrews RM, Zhou F, Hatchett RJ, et al. "Policy making for vaccine use as a driver of vaccine innovation and development in the developed world". Vaccine. (2017).
    39. Golan MS, Trump BD, Cegan JC, Linkov I. "The Vaccine Supply Chain: A Call for Resilience Analytics to Support COVID-19 Vaccine Production and Distribution". arXiv preprint arXiv:201114231. (2020).
    40. Ezzat D, Hassanien AE, Ella HA. "An optimized deep learning architecture for the diagnosis of COVID-19 disease based on gravitational search optimization". Applied Soft Computing. (2020).
    41. Abbasi B, Fadaki M, Kokshagina O, Saeed N, Chhetri P. "Modeling Vaccine Allocations in the COVID-19 Pandemic: A Case Study in Australia". Available at SSRN 3744520. (2020).
    42. Mishra AR, Rani P, Krishankumar R, Ravichandran K, Kar S. "An extended fuzzy decision-making framework using hesitant fuzzy sets for the drug selection to treat the mild symptoms of Coronavirus Disease 2019 (COVID-19)". Applied Soft Computing. (2021).
    43. Rastegar M, Tavana M, Meraj A, Mina H. "An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic". Vaccine. (2021).
    44. Tsuzuki S, Baguelin M, Pebody R, van Leeuwen E. "Modelling the optimal target age group for seasonal influenza vaccination in Japan". Vaccine. (2020).
    45. Esmizadeh Y, Bashiri M, Jahani H, Almada-Lobo B. "Cold chain management in hierarchical operational hub networks". Transportation Research Part E: Logistics and Transportation Review. (2021).
    46. Duijzer LE, Van Jaarsveld W, Dekker R. "Literature review: The vaccine supply chain". European Journal of Operational Research. (2018).
    47. Dai T, Cho S-H, Zhang F. "Contracting for on-time delivery in the US influenza vaccine supply chain". Manufacturing & Service Operations Management. (2016).
    48. Sarley D, Mahmud M, Idris J, Osunkiyesi M, Dibosa-Osadolor O, Okebukola P, et al. "Transforming vaccines supply chains in Nigeria". Vaccine. (2017).
    49. Alizadeh M, Sharbafi F, Paydar MM. "A bi-objective natural disaster blood supply chain network considering blood transfusion: A case study in Babol". International Journal of Industrial Engineering and Management Science. (2020).
    50. Pourmehdi M, Paydar MM, Asadi-Gangraj E. "Scenario-based design of a steel sustainable closed-loop supply chain network considering production technology". Journal of Cleaner Production. (2020).
    51. Alizadeh M, Makui A, Paydar MM. "Forward and reverse supply chain network design for consumer medical supplies considering biological risk". Computers & Industrial Engineering. (2020).
    52. Bozorgi A, Fahimnia B. "Transforming the vaccine supply chain in Australia: Opportunities and challenges". Vaccine. (2021).
    53. Sun X, Andoh EA, Yu H. "A simulation-based analysis for effective distribution of COVID-19 vaccines: A case study in Norway". Transportation Research Interdisciplinary Perspectives. (2021).
    54. Chandra D, Vipin B, Kumar D. "A fuzzy multi-criteria framework to identify barriers and enablers of the next-generation vaccine supply chain". International Journal of Productivity and Performance Management. (2021).
    55. Golan MS, Trump BD, Cegan JC, Linkov I. "The vaccine supply chain: A call for resilience analytics to support COVID-19 vaccine production and distribution". COVID-19: Systemic Risk and Resilience: Springer; (2021).
    56. Bulula N, Mwiru DP, Swalehe O, Mori AT. "Vaccine storage and distribution between expanded program on immunization and medical store department in Tanzania: a cost-minimization analysis". Vaccine. (2020).
    57. de Carvalho MI, Ribeiro D, Barbosa-Povoa AP. "Design and Planning of Sustainable Vaccine Supply Chain". Pharmaceutical Supply Chains-Medicines Shortages: Springer; (2019).
    58. Chandra D, Kumar D. "Prioritizing the vaccine supply chain issues of developing countries using an integrated ISM-fuzzy ANP framework". Journal of Modelling in Management. (2019).
    59. Chandra D, Kumar D. "Analysis of vaccine supply chain issues using ISM approach". International Journal of Logistics Systems and Management. (2018).
    60. Lee BY, Haidari LA, Prosser W, Connor DL, Bechtel R, Dipuve A, et al. "Re-designing the Mozambique vaccine supply chain to improve access to vaccines". Vaccine. (2016).